COVID-19 EUA Vaccine Code Set Release Notes - 12/13/2022

["Centers for Disease Control and Prevention" <no-reply@xxxxxxxxxxxxxxxxxxxx>]

 

If this is a forwarded email, subscribe now to receive future updates on this topic.

 

 

You are subscribed to one or more CDC code set email subscription services. Subscription links are available on each of the pages below.

• https://www2.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx
• https://www2.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=vg
• https://www2.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=mvx
• https://www2.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=tradename
• https://www2.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=ndc
• https://www2.cdc.gov/vaccines/iis/iisstandards/ndc_tableaccess.asp
• https://www2.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cpt
• https://www2.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvxvis
• https://www2a.cdc.gov/vaccines/iis/iisstandards/ndc_tableaccess.asp
• https://www.cdc.gov/vaccines/programs/iis/code-sets/vis-barcode-lookup-table.html

COVID-19 Vaccine Code Set Update Publication Date: December 13 2022
The individual filenames included in this distribution contain the publication date (20221213)

 

Release Notes:  This release includes a COVID-19 new CPT code to CVX map.

 

Release notes are designed as a guide to highlight changes that have been made to the vaccine codes since the last publication.  They should not be used as the primary source of code information.  The vaccine code files themselves should be utilized.

COVID-19 Related Code Updates

1. New CPT Added and Mapped to CVX – Pfizer bivalent vaccine for ages 6 months through 4 years authorized by FDA on 12/08/2022
   • Added:  CPT Code 91317 "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use"
   • Mapped to CVX code 302 "SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulation"
2. Update to CPT Code
   • Note field updated to reflect EUA Authorization date for CPT Code 91316 "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosage, for intramuscular use"

The above updates impact the following vaccine code file:

The CPT codes included in the CDC code sets represent the product codes.  Further guidance and the dose administration codes for this and other COVID-19 CPT codes are available on the AMA website using the following link:

  

https://www.ama-assn.org/practice-management/cpt/covid-19-cpt-vaccine-and-immunization-codes

  

The table on CDC's website  IIS COVID-19 Vaccine Related Code | CDC:  "COVID-19 US Vaccine Codes" has also been updated to incorporate the new CPT code.

  

In addition to the FDA's EUA Fact Sheets for Recipients/Caregivers, the CDC may provide additional or updated clinical guidance for products under EUA.  See the following link for the latest CDC COVID-19 vaccine clinical guidance: Clinical Guidance for COVID-19 Vaccination | CDC

  

Centers for Disease Control and Prevention

1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348
Questions or Problems  |